Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-Mar-12 5:35 PM View:  | Tranzyme, Inc. (OCRX) | 14-Mar-12 | Market Purchase | 12,076 | $3.00 | $36,171.70 | 5% 219.94K to 232.01K | (95%) |
| 14-Mar-12 5:35 PM View: | Tranzyme, Inc. (OCRX) | 13-Mar-12 | Market Purchase | 15,599 | $2.96 | $46,143.40 | 8% 204.34K to 219.94K | (95%) |
| 14-Mar-12 5:35 PM View: | Tranzyme, Inc. (OCRX) | 12-Mar-12 | Market Purchase | 94,306 | $2.44 | $229,685.00 | 86% 110.03K to 204.34K | (94%) |
| 09-Mar-12 6:28 PM View: | Genomic Health Inc. (GHDX) | 08-Mar-12 | Market Purchase | 2,162 | $30.36 | $65,646.50 | < 1% 1.48M to 1.48M | 174% |
| 09-Mar-12 6:28 PM View: | Genomic Health Inc. (GHDX) | 07-Mar-12 | Market Purchase | 2,346 | $29.88 | $70,096.60 | < 1% 1.48M to 1.48M | 179% |
| 05-Mar-12 6:26 PM View: | Genomic Health Inc. (GHDX) | 05-Mar-12 | Market Purchase | 18,597 | $30.01 | $558,037.00 | 1% 1.46M to 1.48M | 178% |
| 05-Mar-12 6:26 PM View: | Genomic Health Inc. (GHDX) | 02-Mar-12 | Market Purchase | 10,972 | $29.52 | $323,899.00 | < 1% 1.45M to 1.46M | 182% |
| 05-Mar-12 6:26 PM View: | Genomic Health Inc. (GHDX) | 01-Mar-12 | Market Purchase | 1,763 | $29.47 | $51,956.30 | < 1% 1.45M to 1.45M | 183% |
| 29-Feb-12 5:39 PM View: | Genomic Health Inc. (GHDX) | 29-Feb-12 | Market Purchase | 19,552 | $29.06 | $568,144.00 | 1% 1.43M to 1.45M | 187% |
| 29-Feb-12 5:39 PM View: | Genomic Health Inc. (GHDX) | 28-Feb-12 | Market Purchase | 5,934 | $29.11 | $172,730.00 | < 1% 1.42M to 1.43M | 186% |
| 29-Feb-12 5:39 PM View: | Genomic Health Inc. (GHDX) | 27-Feb-12 | Market Purchase | 4,270 | $29.03 | $123,961.00 | < 1% 1.42M to 1.42M | 187% |
| 23-Feb-12 6:08 PM View: | Genomic Health Inc. (GHDX) | 23-Feb-12 | Market Purchase | 7,477 | $28.12 | $210,282.00 | < 1% 1.41M to 1.42M | 196% |
| 23-Feb-12 6:08 PM View: | Genomic Health Inc. (GHDX) | 22-Feb-12 | Market Purchase | 638 | $27.98 | $17,851.90 | < 1% 1.41M to 1.41M | 198% |
| 23-Feb-12 6:08 PM View: | Genomic Health Inc. (GHDX) | 21-Feb-12 | Market Purchase | 5,217 | $27.98 | $145,955.00 | < 1% 1.41M to 1.41M | 198% |
| 16-Feb-12 6:58 PM View: | Genomic Health Inc. (GHDX) | 16-Feb-12 | Market Purchase | 21,900 | $29.73 | $651,092.00 | 2% 1.38M to 1.41M | 180% |
| 16-Feb-12 6:58 PM View: | Genomic Health Inc. (GHDX) | 15-Feb-12 | Market Purchase | 3,944 | $28.88 | $113,892.00 | < 1% 1.38M to 1.38M | 189% |
| 16-Feb-12 6:58 PM View: | Genomic Health Inc. (GHDX) | 14-Feb-12 | Market Purchase | 7,341 | $28.44 | $208,756.00 | < 1% 1.37M to 1.38M | 193% |
| 14-Feb-12 5:53 PM View: | Pharmacyclics Inc. (PCYC) | 10-Feb-12 | Market Purchase | 150,000 | $20.85 | $3,128,040.00 | 37% 407.21K to 557.21K | 1153% |
| 10-Feb-12 9:33 PM View: | Genomic Health Inc. (GHDX) | 10-Feb-12 | Market Purchase | 24,582 | $26.59 | $653,635.00 | 2% 1.35M to 1.37M | 213% |
| 10-Feb-12 9:33 PM View: | Genomic Health Inc. (GHDX) | 09-Feb-12 | Market Purchase | 8,860 | $26.32 | $233,174.00 | < 1% 1.34M to 1.35M | 217% |
| 10-Feb-12 9:33 PM View: | Genomic Health Inc. (GHDX) | 08-Feb-12 | Market Purchase | 33,141 | $26.20 | $868,267.00 | 3% 1.31M to 1.34M | 218% |
| 26-Jan-12 6:12 PM View: | Pharmacyclics Inc. (PCYC) | 26-Jan-12 | Market Purchase | 41,873 | $17.93 | $750,902.00 | 11% 365.34K to 407.21K | 1357% |
| 26-Jan-12 6:12 PM View: | Pharmacyclics Inc. (PCYC) | 25-Jan-12 | Market Purchase | 21,565 | $18.53 | $399,626.00 | 6% 343.77K to 365.34K | 1310% |
| 26-Jan-12 6:12 PM View: | Pharmacyclics Inc. (PCYC) | 24-Jan-12 | Market Purchase | 22,555 | $17.95 | $404,958.00 | 7% 321.22K to 343.77K | 1355% |
| 23-Jan-12 8:39 PM View: | Pharmacyclics Inc. (PCYC) | 23-Jan-12 | Market Purchase | 28,209 | $16.87 | $475,963.00 | 10% 293.01K to 321.22K | 1448% |
| 23-Jan-12 8:39 PM View: | Pharmacyclics Inc. (PCYC) | 20-Jan-12 | Market Purchase | 43,156 | $16.42 | $708,524.00 | 18% 245.45K to 288.61K | 1491% |
| 23-Jan-12 8:39 PM View: | Pharmacyclics Inc. (PCYC) | 20-Jan-12 | Exercise (in-the money or at-the-money) | 4,400 | $15.00 | $66,000.00 | 2% 288.61K to 293.01K | 1642% |
| 23-Jan-12 8:39 PM View: | Pharmacyclics Inc. (PCYC) | 19-Jan-12 | Market Purchase | 6,060 | $16.05 | $97,263.60 | 3% 239.39K to 245.45K | 1528% |
| 09-Jan-12 7:00 PM View: | Trimeris Inc. (GEVA) | 05-Jan-12 | Grant | 187,576 | $25.18 | $4,723,160.00 | 12% 1.55M to 1.74M | 837% |
| 04-Jan-12 7:24 PM View: | Seattle Genetics Inc. (SGEN) | 30-Dec-11 | Exercise (in-the money or at-the-money) | 339,788 | $6.25 | $2,123,680.00 | 7% 4.63M to 4.97M | |
| 03-Jan-12 6:01 PM View: | Adolor Corp. (ADLR) | 19-Dec-11 | Disposition (change in control) | 79,054 | $4.25 | $335,980.00 | (100%) 79.05K to 0 | |
| 16-Dec-11 4:27 PM View: | ViroPharma Inc. (VPHM) | 14-Dec-11 | Market Purchase | 50,566 | $27.29 | $1,379,860.00 | 3% 1.92M to 1.97M | 82% |
| 05-Dec-11 6:18 PM View: | Genomic Health Inc. (GHDX) | 05-Dec-11 | Market Purchase | 3,377 | $28.45 | $96,091.90 | < 1% 1.3M to 1.31M | 193% |
| 06-Dec-11 6:12 PM View: | Pharmacyclics Inc. (PCYC) | 02-Dec-11 | Market Purchase | 14,561 | $15.42 | $224,467.00 | 6% 224.83K to 239.39K | 1595% |
| 05-Dec-11 6:18 PM View: | Genomic Health Inc. (GHDX) | 02-Dec-11 | Market Purchase | 16,063 | $28.05 | $450,585.00 | 1% 1.29M to 1.3M | 197% |
| 05-Dec-11 6:18 PM View: | Genomic Health Inc. (GHDX) | 01-Dec-11 | Market Purchase | 26,537 | $27.33 | $725,256.00 | 2% 1.26M to 1.29M | 205% |
| 30-Nov-11 6:19 PM View: | Pharmacyclics Inc. (PCYC) | 30-Nov-11 | Market Purchase | 11,164 | $14.92 | $166,590.00 | 5% 213.67K to 224.83K | 1651% |
| 30-Nov-11 6:19 PM View: | Pharmacyclics Inc. (PCYC) | 29-Nov-11 | Market Purchase | 27,871 | $14.18 | $395,098.00 | 15% 185.8K to 213.67K | 1743% |
| 30-Nov-11 6:19 PM View: | Pharmacyclics Inc. (PCYC) | 28-Nov-11 | Market Purchase | 25,764 | $13.34 | $343,702.00 | 16% 160.03K to 185.8K | 1858% |
| 23-Nov-11 5:03 PM View: | Pharmacyclics Inc. (PCYC) | 23-Nov-11 | Market Purchase | 3,141 | $12.76 | $40,079.50 | 2% 156.89K to 160.03K | 1948% |
| 23-Nov-11 4:59 PM View: | Genomic Health Inc. (GHDX) | 23-Nov-11 | Market Purchase | 2,273 | $25.83 | $58,714.30 | < 1% 1.26M to 1.26M | 223% |
| 23-Nov-11 5:03 PM View: | Pharmacyclics Inc. (PCYC) | 22-Nov-11 | Market Purchase | 2,780 | $12.78 | $35,538.20 | 2% 154.11K to 156.89K | 1944% |
| 23-Nov-11 4:59 PM View: | Genomic Health Inc. (GHDX) | 22-Nov-11 | Market Purchase | 1,628 | $26.03 | $42,377.20 | < 1% 1.26M to 1.26M | 220% |
| 23-Nov-11 5:03 PM View: | Pharmacyclics Inc. (PCYC) | 21-Nov-11 | Market Purchase | 1,430 | $12.07 | $17,258.10 | < 1% 152.68K to 154.11K | 2065% |
| 23-Nov-11 4:59 PM View: | Genomic Health Inc. (GHDX) | 21-Nov-11 | Market Purchase | 1,630 | $25.91 | $42,225.20 | < 1% 1.25M to 1.26M | 222% |
| 17-Nov-11 5:34 PM View: | Genomic Health Inc. (GHDX) | 16-Nov-11 | Market Purchase | 458 | $27.35 | $12,524.70 | < 1% 1.25M to 1.25M | 205% |
| 14-Nov-11 5:17 PM View: | Genomic Health Inc. (GHDX) | 09-Nov-11 | Market Purchase | 542 | $26.79 | $14,519.70 | < 1% 1.25M to 1.25M | 211% |
| 07-Nov-11 6:08 PM View: | Genomic Health Inc. (GHDX) | 03-Nov-11 | Market Purchase | 120 | $24.48 | $2,937.98 | < 1% 1.25M to 1.25M | 240% |
| 04-Nov-11 8:32 PM View: | Trimeris Inc. (GEVA) | 02-Nov-11 | Grant | 1,297,870 | -- | -- | 518% 250.62K to 1.55M | |
| 06-Oct-11 5:36 PM View: | ViroPharma Inc. (VPHM) | 05-Oct-11 | Market Purchase | 16,278 | $18.18 | $295,984.00 | < 1% 1.9M to 1.92M | 174% |